Google Life Sciences Rechristened As Verily

Alphabet, the new parent company of Google, has renamed the Life Sciences division as Verily – an independent Alphabet company that aims to bring together technology and life sciences to uncover new truths about health and disease.

“Verily is focused on using technology to better understand health, as well as prevent, detect, and manage disease”, the official website reads. “Our multidisciplinary teams have access to advanced research tools, large scale computing power, and unique technical expertise. We work with partners from across the industry and many fields of research to develop new technology, launch studies, and start companies”.

According to verily.com, the company’s hardware team is involved in building tools and devices that are smaller, more powerful, and more convenient than before. Currently, the company is partnering to develop a contact lens with an embedded glucose sensor that will make it easier for people with diabetes to monitor themselves continuously by measuring the glucose in their tears.

The software team is developing platforms, products, and algorithms that can analyze complex health information. The clinical team works to surface information and insights that benefit the health research community for years to come. And lastly, the science team is pursuing research that will help to better understand the processes that lead to conditions like cancer, heart disease, and diabetes.

Google embarked on a project in 2012 to put computing inside a contact lens which has important application to health. Google Life Sciences (GLS) aimed at shifting health care from a reactive, undifferentiated approach to a proactive, targeted approach by transforming the detection, prevention, management and even basic understanding of disease.